U.S. Department of Homeland Security Certifies BioThrax(R) (Anthrax Vaccine Adsorbed) As An Approved Product For Homeland Security.

PR Newswire Europe, August, 2006

GAITHERSBURG, Maryland, August 29 /PRNewswire/ --

- BioThrax(R) is the First Known Vaccine to Obtain SAFETY Act Protections

Emergent BioSolutions Inc., a privately held biopharmaceutical company, today announced that the United States Department of Homeland Security (DHS) has granted the company's application for designation and certification of BioThrax(R) (Anthrax Vaccine Adsorbed) as a "qualified anti-terrorism technology" under the "Support Anti-Terrorism by Fostering Effective Technology Act" (SAFETY Act). BioThrax(R), the only FDA-approved vaccine for the prevention of anthrax infection, is the first known vaccine to be granted such SAFETY Act coverage. BioThrax(R) is manufactured by BioPort Corporation, a subsidiary of Emergent BioSolutions....

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement